National Center of Neurology and Psychiatry

Chugai Seiyaku Kabushiki Kaisha

Kabushiki Kaisha Yakult Honsha

Dna Chip Research Inc.

Hiroshi Kunugi

Chisato Wakabayashi

Hirokazu Tsuji

Ryo Matoba

Seiji Nakamura

Yoshitatsu Ichihara

Emiko Aizawa

Yohei Ishizawa

Kenichi Matsubara

Hiroaki Hori

Miho Ota

Junko Matsuo

A marker for determining a mental disease is provided. The marker can be used in an objective diagnosis of such a mental disease. The marker contains one or more enterobacteria ofsubgroup,subgroup,cluster,group,group,subgroup,, and

Biomarker for mental disease

The object of the invention is to provide a method for easily and objectively detecting mood disorders in a subject by measuring the expression levels of prescribed genes in the peripheral blood of the subject, the reliability of the detection result being high. The invention also provides a method for detecting mood disorders in a subject, the method having a step for measuring the gene expression levels of ribosomal protein genes, CDKN1C, or any combination thereof in the peripheral blood derived from the subject, and detecting whether or not the subject has mood disorders on the basis of the measurement results.

Method for detecting mood disorders

The present invention provides a novel therapeutic agent for mental illness. The therapeutic agent for mental illness comprises an IL-6 inhibitor as an active ingredient.

Therapeutic agent for mental illness comprising IL-6 inhibitor as active ingredient

Growing community of inventors

Tokyo, Japan

Hiroshi Kunugi